Compound 2309
Identifiers
- Canonical SMILES:
NC(=O)NCC(=O)NCc1csc2ccccc12
- IUPAC name:
N-[(1-benzothiophen-3-yl)methyl]-2-(carbamoylamino)acetamide
- InChi:
InChI=1S/C12H13N3O2S/c13-12(17)15-6-11(16)14-5-8-7-18-10-4-2-1-3-9(8)10/h1-4,7H,5-6H2,(H,14,16)(H3,13,15,17)
- InChiKey:
HAVSKPTVGCVYLJ-UHFFFAOYSA-N
External links
![]() 127266493 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
2 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BAZ2-like PHD / H3 | 2.64 | prostate cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 263.07 g/mol | |||
HBA | 5 | |||
HBD | 4 | |||
HBA + HBD | 9 | |||
AlogP | 0.36 | |||
TPSA | 84.22 | |||
RB | 4 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 2 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
10.1021/acschembio.7b01093 | Fr18 | BAZ2A Q9UIF9 |
H31 P68431 |
Biochemical assay | NMR chemical-shift perturbation BAZ2A PHD | pKd (dissociation constant, -log10) | 2.05 | |
10.1021/acschembio.7b01093 | Fr18 | BAZ2A Q9UIF9 |
H31 P68431 |
Biochemical assay | NMR chemical-shift perturbation BAZ2B PHD | pKd (dissociation constant, -log10) | 2.64 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.6240 | GLPG-0974 | DB15406 | |
0.4464 | (S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentylamino)ethanoyl)pyrrolidine-2-carboxamide | DB06845 | |
0.4464 | 1-[(2R)-2-aminobutanoyl]-N-(3-chlorobenzyl)-L-prolinamide | DB06878 | |
0.4464 | D-leucyl-N-(3-chlorobenzyl)-L-prolinamide | DB06911 | |
0.4464 | 1-[(2R)-2-aminobutanoyl]-N-(4-carbamimidoylbenzyl)-L-prolinamide | DB06947 | |
0.4464 | D-leucyl-N-(4-carbamimidoylbenzyl)-L-prolinamide | DB06996 | |
0.4414 | N-(3-chlorobenzyl)-1-(4-methylpentanoyl)-L-prolinamide | DB06868 | |
0.4414 | 1-butanoyl-N-(4-carbamimidoylbenzyl)-L-prolinamide | DB06929 | |
0.4414 | N-(4-carbamimidoylbenzyl)-1-(4-methylpentanoyl)-L-prolinamide | DB06936 | |
0.4397 | 3-cyclohexyl-D-alanyl-N-(3-chlorobenzyl)-L-prolinamide | DB07190 | |
0.4397 | Thalidomide | DB01041 | |
0.4386 | (S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexylamino)ethanoyl)pyrrolidine-2-carboxamide | DB06850 | |
0.4386 | N-cyclooctylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide | DB06858 | |
0.4386 | Proglumide | DB13431 | |
0.4375 | Ethotoin | DB00754 |